血糖对痴呆风险的影响:115,875名个体的孟德尔随机化研究
该研究采用孟德尔随机化设计,纳入哥本哈根普通人群研究和哥本哈根城市心脏研究的115,875名个体,并在455,258名个体的两样本孟德尔随机化设计中验证阿尔茨海默病结果。观察性和遗传性高血糖与未特指痴呆风险存在因果关联,但与阿尔茨海默病或血管性痴呆无关。
要点
- 观察性分析中,血糖高于7 vs 5-6 mmol/l的未特指痴呆HR为1.15(95% CI 1.01, 1.32;p=0.039)。
- 遗传因果分析中,血浆血糖每升高1 mmol/l,未特指痴呆的RR为2.40(95% CI 1.18, 4.89;p=0.016)。
- 高血糖与阿尔茨海默病和血管性痴呆无显著因果关联。
核心结论
- 观察性和遗传性高血浆葡萄糖与未特指痴呆风险存在因果关联,但与阿尔茨海默病或血管性痴呆无关。
研究设计与样本
- 采用孟德尔随机化设计,数据来自哥本哈根普通人群研究和哥本哈根城市心脏研究的115,875名个体。
- 阿尔茨海默病结果在包含455,258名个体的两样本孟德尔随机化设计中验证,其中71,880名个体患有阿尔茨海默病或父母患有阿尔茨海默病。
主要发现
- 观察性多因素校正分析中,血糖高于7 vs 5-6 mmol/l的未特指痴呆HR为1.15(95% CI 1.01, 1.32;p=0.039),阿尔茨海默病HR为0.91(95% CI 0.79, 1.06;p=0.22),血管性痴呆HR为1.16(95% CI 0.86, 1.55;p=0.34)。
- 有 vs 无2型糖尿病的未特指痴呆HR为1.42(95% CI 1.24, 1.63;p<0.001),阿尔茨海默病HR为1.11(95% CI 0.95, 1.29;p=0.18),血管性痴呆HR为1.73(95% CI 1.31, 2.27;p<0.001)。
- 遗传因果分析中,血浆血糖每升高1 mmol/l,未特指痴呆RR为2.40(95% CI 1.18, 4.89;p=0.016),阿尔茨海默病RR为1.41(95% CI 0.82, 2.43;p=0.22),血管性痴呆RR为1.20(95% CI 0.82, 1.75;p=0.36)。
- MAGIC与ADSP、IGAP、PGC-ALZ和UKB联盟的汇总数据给出阿尔茨海默病RR为1.02(95% CI 0.92, 1.13;p=0.42),该联盟联合哥本哈根研究给出阿尔茨海默病RR为1.03(95% CI 0.93, 1.13;p=0.36)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Mendelian randomisation studies have not shown a clear causal effect of high plasma glucose on the risk of Alzheimer's disease. We tested the hypothesis that high plasma glucose caused by genetic variation has a causal effect on the risk of unspecified dementia, Alzheimer's disease and vascular dementia in the general population. METHODS: A Mendelian randomisation design was used with data from 115,875 individuals from the Copenhagen General Population Study and the Copenhagen City Heart Study. Findings for Alzheimer's disease were validated in a two-sample Mendelian design with 455,258 individuals, including 71,880 individuals with Alzheimer's disease or a parent with Alzheimer's disease. RESULTS: In observational multifactorial-adjusted analyses, HRs were 1.15 (95% CI 1.01, 1.32; p = 0.039) for unspecified dementia, 0.91 (95% CI 0.79, 1.06; p = 0.22) for Alzheimer's disease and 1.16 (95% CI 0.86, 1.55; p = 0.34) for vascular dementia in individuals with a glucose level higher than 7 vs 5-6 mmol/l. Corresponding HRs in individuals with vs without type 2 diabetes were 1.42 (95% CI 1.24, 1.63; p < 0.001), 1.11 (95% CI 0.95, 1.29; p = 0.18) and 1.73 (95% CI 1.31, 2.27; p < 0.001). In genetic causal analyses, a 1 mmol/l higher plasma glucose level had RRs of 2.40 (95% CI 1.18, 4.89; p = 0.016) for unspecified dementia, 1.41 (95% CI 0.82, 2.43; p = 0.22) for Alzheimer's disease and 1.20 (95% CI 0.82, 1.75; p = 0.36) for vascular dementia. Summary-level data from the Meta-Analyses of Glucose and Insulin-related Traits Consortium (MAGIC) combined with a consortium of the Alzheimer's Disease Sequencing Project (ADSP), the International Genomics of Alzheimer's Project (IGAP), the Alzheimer's Disease Working Group of the Psychiatric Genomics Consortium (PGC-ALZ) and the UK Biobank (UKB) gave an RR for Alzheimer's disease of 1.02 (95% CI 0.92, 1.13; p = 0.42), and this consortium combined with Copenhagen studies gave an RR for Alzheimer's disease of 1.03 (95% CI 0.93, 1.13; p = 0.36). CONCLUSIONS/INTERPRETATION: Observational and genetically high plasma glucose are causally related to the risk of unspecified dementia, but not to Alzheimer's disease or vascular dementia.
引用
- Benn M, Nordestgaard BG, Tybjærg-Hansen A, et al. Impact of glucose on risk of dementia: Mendelian randomisation studies in 115,875 individuals. Diabetologia. 2020. PMID: 32172311. doi:10.1007/s00125-020-05124-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。